Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines 

Targeting the RB-pathway in Cancer Therapy

(2010) E. S. Knudsen et al.   CLINICAL CANCER RESEARCH

Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure

(2010) J L Dean et al.   ONCOGENE

Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells

(2009) N Johnson et al.   BRITISH JOURNAL OF CANCER

Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy

(2009) Alessandro Sgambato et al.   CANCER SCIENCE

Cyclin E deregulation is an early event in the development of breast cancer

(2008) Alexandra Shaye et al.   BREAST CANCER RESEARCH AND TREATMENT

Familial Breast Cancers without Mutations in BRCA1 or BRCA2 Have Low Cyclin E and High Cyclin D1 in Contrast to Cancers in BRCA Mutation Carriers

(2008) K. Aaltonen et al.   CLINICAL CANCER RESEARCH